{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:46:01Z","timestamp":1770907561258,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Schistosomiasis is a widely distributed parasitic disease and one of the most important neglected tropical diseases globally, for which Praziquantel\u00ae (PZQ) is the only available treatment. In this context, tests with new PZQ formulations become relevant for disease control. This study evaluated the effects of PZQ treatment in the prepatent phase of schistosomiasis using two formulations: nanoencapsulated (PZQ-NANO) and active pharmaceutical ingredient (PZQ-API). Five experimental groups were established, for which the following serological parameters were evaluated: ALT, AST, ALP, and TP. Animals treated with PZQ-API at 15 and 30 days post-infection showed decreased eggs per gram of feces (EPG) compared to untreated infected animals. The same animals showed reductions of 63.6 and 65.1%, respectively, at 60 days post-infection. Animals treated with PZQ-NANO experienced no significant changes in EPG at any time of observation. Animals treated with either PZQ-API or PZQ-NANO had higher ALT and AST levels in the patent period (60 and 90 days post-infection). Treatment with PZQ, either API or NANO, at 15 days post-infection reduced AST, ALT, and TP levels. It is concluded that prepatent treatment with PZQ-API can reduce the parasite load of infected animals and that treatment at 15 days post-infection can prevent increased serum levels of ALT, AST, and TP.<\/jats:p>","DOI":"10.3389\/fpubh.2022.848633","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T06:26:46Z","timestamp":1653632806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models"],"prefix":"10.3389","volume":"10","author":[{"given":"\u00c9rica Tex","family":"Paulino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Ribeiro de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Lifsitch","family":"Vi\u00e7osa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleber Hooper da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Javier","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Andr\u00e9s","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9lia Christina","family":"Mello Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Henrique Almeida de","family":"Moraes Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"B1","unstructured":"Schistosomiasis2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/978-3-7091-1422-3_2","article-title":"\u201cSchistosomiasis in America\u201d,","volume-title":"Neglected Tropical Diseases\u2014Latin America and the Caribbean","author":"Noya","year":"2015"},{"key":"B5","unstructured":"Portal da Sa\u00fade SUS\u2014Datasus. Informa\u00e7\u00f5es da sa\u00fade\u2014demogr\u00e1ficas e socioecon\u00f4micas [Internet]2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1371\/journal.pntd.0001138","article-title":"Potential drug development candidates for human soil-transmitted helminthiases","volume":"5","author":"Olliaro","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B7","article-title":"\u201cTerap\u00eautica Cl\u00ednica na Esquistossomose Mansoni\u201d","volume-title":"Schistosoma mansoni e esquistossomose: uma vis\u00e3o multidisciplinar","author":"Katz","year":"2008"},{"key":"B8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/infdis\/159.3.589","article-title":"Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni","volume":"159","author":"Xiao","year":"1989","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/0035-9203(87)90360-9","article-title":"Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice","volume":"81","author":"Doenhoff","year":"1987","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00436-002-0751-z","article-title":"Praziquantel","volume":"90","author":"Cioli","year":"2003","journal-title":"Parasitol Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ijpara.2005.05.002","article-title":"Effect of praziquantel on the immature stages of Schistosoma haematobium","volume":"32","author":"Botros","year":"2005","journal-title":"Int J Parasitol"},{"key":"B12","first-page":"121","article-title":"Quantitative aspects of the migration and evolutive asynchronism of Schistosoma mansoni in mice","volume":"20","author":"Barbosa","year":"1978","journal-title":"Rev Inst Med Trop S\u00e3o Paulo."},{"key":"B13","first-page":"133","article-title":"Studies on schistosomiasis mansoni in Puerto Rico. III- Biological studies 2 The mammalian phase of the life cycle","volume":"10","author":"Faust","year":"1934","journal-title":"P R Health Sci J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1590\/0074-0276130135","article-title":"Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection","volume":"108","author":"Vimeiro","year":"2013","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.25258\/ijpcr.v9i3.8324","article-title":"Microencapsulation and nanoencapsulation: a review","volume":"9","author":"Suganya","year":"2017","journal-title":"Int J Phar Clin Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105714","DOI":"10.1016\/j.actatropica.2020.105714","article-title":"Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni","volume":"212","author":"Eissa","year":"2020","journal-title":"Acta Trop."},{"key":"B17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13071-020-04346-1","article-title":"Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni","volume":"13","author":"Eissa","year":"2020","journal-title":"Parasit Vectors"},{"key":"B18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2307\/3277297","article-title":"A rapid method of infecting mice and other laboratory animals with Schistosoma mansoni: subcutaneous injection","volume":"55","author":"Peters","year":"1969","journal-title":"J Parasitol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1021\/js950164r","article-title":"Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement","volume":"85","author":"Molpeceres","year":"1996","journal-title":"J Pharm Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0378-5173(99)00216-1","article-title":"Alle'mann E, Fessi H, Doelker E. Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation","volume":"188","author":"Quintanar-Guerrero","year":"1999","journal-title":"Int J of Pharm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0074-02762011000200006","article-title":"Schistosoma mansoni: a method for inducing resistance to praziquantel using infect Biomphalaria glabrata snails","volume":"106","author":"Couto","year":"2011","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1590\/S0037-86821996000500010","article-title":"Suscetibilidade aos agentes quimioter\u00e1picos de isolados de Schistosoma mansoni oriundos de pacientes tratados com oxamniquine e praziquantel e n\u00e3o curados","volume":"29","author":"Ara\u00fajo","year":"1996","journal-title":"Rev Soc Bras Med Trop."},{"key":"B23","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni","volume":"14","author":"Katz","year":"1972","journal-title":"Rev Inst Med Trop S Paulo."},{"key":"B24","volume-title":"Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee","year":"2002"},{"key":"B25","volume-title":"R: A Language and Environment for Statistical Computing Version 3.5.2","year":"2018"},{"key":"B26","volume-title":"Vigil\u00e2ncia da esquistossomose mans\u00f4nica: diretrizes t\u00e9cnicas","year":"2014"},{"key":"B27","volume-title":"Schistosomiasis: progress report 2001-\u22122011, strategic plan 2012-\u22122020","year":"2013"},{"key":"B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"A new broad-spectrum antischistosomal agent","volume":"52","author":"G\u00f6nnert","year":"1977","journal-title":"Z Parasitenkd."},{"key":"B29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","article-title":"Schistosoma mansoni: chemotherapy of infections of different ages","volume":"61","author":"Sabah","year":"1986","journal-title":"Exp Parasitol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex-and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"Pica-Mattoccia","year":"2004","journal-title":"Int J Parasitol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF00927527","article-title":"Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro","volume":"63","author":"Becker","year":"1980","journal-title":"Z Parasitenkd."},{"key":"B32","first-page":"544","article-title":"In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. a light and electron microscopic study","volume":"31","author":"Mehlhorn","year":"1981","journal-title":"Arzneimittelforschung."},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","article-title":"Antischistosomal drugs: past, present and future?","volume":"68","author":"Cioli","year":"1995","journal-title":"Pharmacol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0004946","DOI":"10.1371\/journal.pntd.0004946","article-title":"Expanding praziquantel (PZQ) access beyond mass drug administration programs: paving a way forward for a pediatric PZQ formulation for schistosomiasis","volume":"10","author":"Bustinduy","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1128\/CMR.00137-14","article-title":"Advances in the diagnosis of human schistosomiasis","volume":"28","author":"Weerakoon","year":"2015","journal-title":"Clinic Microbiol Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0169-4758(98)01311-8","article-title":"Morbidity in schistosomiasis: assessment, mechanisms and control","volume":"14","author":"Vennervald","year":"1998","journal-title":"Parasitol Today."},{"key":"B37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.trstmh.2004.06.003","article-title":"Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda","volume":"98","author":"Kabatereine","year":"2004","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-9957-3-23","article-title":"Community-based interventions for the prevention and control of helmintic neglected tropical diseases","volume":"3","author":"Salam","year":"2014","journal-title":"Infect Dis Poverty."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13346-018-0576-7","article-title":"In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions\u2014a metabolic approach","volume":"18","author":"Silva","year":"2018","journal-title":"Drug Deliv Transl Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.actatropica.2017.02.019","article-title":"Nanopharmaceuticals as a solution to neglected diseases: is it possible?","volume":"170","author":"Islan","year":"2017","journal-title":"Acta Trop."},{"key":"B41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.toxrep.2019.04.004","article-title":"Role of nanostructures in improvising oral medicine","volume":"6","author":"Ghosh","year":"2019","journal-title":"Toxicol Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.2147\/IJN.S167285","article-title":"Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting","volume":"13","author":"Amara","year":"2018","journal-title":"Int J Nanomedicine."},{"key":"B43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1166\/jnn.2015.9186","article-title":"Nanostructured lipid carriers as a strategy to improve the in vitro schistosomiasis activity of praziquantel","volume":"15","author":"Kolenyak-Santos","year":"2015","journal-title":"J Nanosci Nanotechnol."},{"key":"B44","first-page":"384","article-title":"Growth performance and serum biochemical parameters as affected by nano zinc supplementation in layer chicks","volume":"31","author":"Mishra","year":"2014","journal-title":"Indian J Anim Nutr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1691\/ph.2009.8140","article-title":"Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles","volume":"64","author":"Yang","year":"2009","journal-title":"Pharmazie."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1017\/S0031182009005708","article-title":"The saga of schistosome migration and attrition","volume":"136","author":"Wilson","year":"2009","journal-title":"Parasitology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1600-065X.1982.tb00377.x","article-title":"The Secret of the Immunopathogenesis of Schistosomiasis: IN VIVO Models","volume":"61","author":"Warren","year":"1982","journal-title":"Immunol Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.0105-2896.2004.00176.x","article-title":"Immunopathogenesis of schistosomiasis","volume":"201","author":"Wynn","year":"2004","journal-title":"Immunol Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12098-007-0118-7","article-title":"Liver function tests and their interpretation","volume":"74","author":"Thapa","year":"2007","journal-title":"Indian J Pediatr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12906-015-0788-z","article-title":"Schistosomicidal, hepatoprotective and antioxidant activities of the methanolic fraction from Clerodendrum umbellatum Poir leaves aqueous extract in Schistosoma mansoni infection in mice","volume":"15","author":"Jatsa","year":"2015","journal-title":"BMC Complement Altern Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5581\/1516-8484.20130098","article-title":"Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis","volume":"35","author":"Leite","year":"2013","journal-title":"Rev Bras Hematol Hemoter."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0135370","DOI":"10.1371\/journal.pone.0135370","article-title":"Splenectomy improves hemostatic and liver functions in hepatosplenic schistosomaisis mansoni","volume":"10","author":"Leite","year":"2015","journal-title":"PLoS One."},{"key":"B53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1590\/S0034-89101981000200004","article-title":"Esquistossomose mans\u00f4nica II \u2014 Evolu\u00e7\u00e3o dos n\u00edveis de prote\u00ednas s\u00e9ricas e do perfil eletrofor\u00e9tico por t\u00e9cnicas de imunoeletroforese quantitativa","volume":"15","author":"Atta","year":"1981","journal-title":"Rev Saude Publ."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.biopha.2017.09.015","article-title":"Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study","volume":"95","author":"Elhenawy","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.imbio.2008.11.017","article-title":"Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni","volume":"214","author":"Allam","year":"2009","journal-title":"Immunobiology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12906-016-1389-1","article-title":"Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress","volume":"16","author":"Al-Olayan","year":"2016","journal-title":"BMC Complement Altern Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.848633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T06:27:02Z","timestamp":1653632822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.848633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":56,"alternative-id":["10.3389\/fpubh.2022.848633"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.848633","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"848633"}}